Foralumab is the only fully human anti-CD3 monoclonal antibody in clinical development for intranasal delivery. By modulating ...

The culmination of Stevens' comprehensive capstone experience took center stage May 9 as the annual Innovation Expo filled ...

Integrating a blood-based biomarker assay into clinical workflows can enhance decision-making in patients with multiple ...

To explore the role of brain and spinal cord MRI features in differentiating patients with suspected central nervous system (CNS) inflammatory diseases.Prospective data from 125 patients undergoing ...

Biomedical engineers at Duke University have developed a novel imaging system that harnesses the power of artificial ...

Contineum Therapeutics, Inc. (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology ...

for Multiple Sclerosis (“MS”). These studies were commissioned to provide data to support an IND application with the US FDA. “We are very pleased to have completed dosing in these toxicity ...

Researchers using simultaneous PET/MRI imaging can measure multiple physiological processes concurrently with exceptional tissue contrast, quantitative accuracy, and study throughput. Sequential ...

Once prostate cancer no longer responds to hormonal therapy, the cancer is called castration-resistant. Find out which ...

Patients with relapsing-remitting multiple sclerosis (RRMS) in England, Wales and Northern Ireland can now access treatment with Biogen's oral therapy Vumerity, after NICE recommended the drug for ...

Weill Cornell Medicine in the US has secured a grant of approximately $4m from the National Cancer Institute for a clinical ...